Partnerships, Licensing, Investments and M&A Deals and Trends for December 2017 in Pharmaceuticals

2018-02-02
Price :
Published : Feb-2018
No. of Pages : 88

Partnerships, Licensing, Investments and M&A Deals and Trends for December 2017 in Pharmaceuticals

Summary

GlobalData’s “Partnerships, Licensing, Investments and M&A Deals and Trends for December 2017 in Pharmaceuticals”, report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in December 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in December 2017. The industry reported 375 deals worth USD21 billion in December 2017, compared to 403 deals worth USD27.5 billion in November 2017. The oncology therapeutics market remained at the top in deal activity in December 2017 with 124 deals. In second place, central nervous system therapeutics market reported 77 deals. Licensing agreements in pharmaceutical and healthcare industry registered an increase in upfront payments. The segment reported USD551.2m as upfront payments in December 2017, compared to USD185.9m in November 2017. The number of deals in North America a decreased to 210 in December 2017 from 241 in November 2017.

Scope

– Analysis of the market trends for the pharmaceutical industry in the global arena.
– Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women’s health segments.
– Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
– Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
– Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
– Analysis of partnership and licensing deals based on clinical stage of development of products.
– Summary of the pharmaceutical deals globally in the six months.
– Information on the top deals happened in the pharmaceutical industry.
– Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
– League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

– Enhance your decision making capability in a more rapid and time sensitive manner.
– Find out the major deal performing segments for investments in your industry.
– Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
– Identify companies that are aggressively looking to raise capital in the market
– Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
– Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
– Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
– Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
– Identify growth segments and opportunities in each region within the industry.
– Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Self Testing – Medical Devices Pipeline Assessment, 2018

Self Testing - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Self Testing - Medical Devices Pipeline Assessment, 2018" provides an overview of Self Testing currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Self Testing pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry e......
$2500

Hemostasis Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2018

Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018" provides an overview of Hemostasis Rapid Tests & Point of Care (POC) currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Rapid Tests & Point of Care (POC) pipeline products. This ......
$2500

Hematology Reagents – Medical Devices Pipeline Assessment, 2018

Hematology Reagents - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Hematology Reagents - Medical Devices Pipeline Assessment, 2018" provides an overview of Hematology Reagents currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Reagents pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Glo......
$2500

Anemia Tests – Medical Devices Pipeline Assessment, 2018

Anemia Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Anemia Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Anemia Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Anemia Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry e......
$2500

Hematology Analyzers – Medical Devices Pipeline Assessment, 2018

Hematology Analyzers - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Hematology Analyzers - Medical Devices Pipeline Assessment, 2018" provides an overview of Hematology Analyzers currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Analyzers pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by......
$2500

Thyroid Function Tests – Medical Devices Pipeline Assessment, 2018

Thyroid Function Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Thyroid Function Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Thyroid Function Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Thyroid Function Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary res......
$4000

Hematology Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2018

Hematology Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Hematology Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018" provides an overview of Hematology Rapid Tests & Point of Care (POC) currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Rapid Tests & Point of Care (POC) pipeline products. This ......
$2500

Cervical Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2018

Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Cervical Cancer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cervical Cancer Diagnostic Tests pipeline products. This report is prepared using data sourced from in-ho......
$2500

Coagulation Analyzers – Medical Devices Pipeline Assessment, 2018

Coagulation Analyzers - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Coagulation Analyzers - Medical Devices Pipeline Assessment, 2018" provides an overview of Coagulation Analyzers currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coagulation Analyzers pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary researc......
$2500

Endocrinology Tests – Medical Devices Pipeline Assessment, 2018

Endocrinology Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Endocrinology Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Endocrinology Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Endocrinology Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Glo......
$4000
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy